Our transplant team members are committed to providing the highest quality transplant services in a family-centered environment. Our uniquely qualified staff members work with patient, family and referring physicians to ensure optimal treatment before, during and after transplant.
- In 2012, our surgeons performed the first heart-liver transplant on a child, birth to age 17, in Wisconsin. This was also the 10th surgery of its kind ever performed on a child in the United States.
- Liver transplants performed at Children's Hospital include live donor (in which a healthy person donates a part of his or her liver), deceased donor, and split and reduced liver transplants (which involve use of an organ from a cadaver).
- We perform unique, successful liver transplants such as liver-kidney and bone marrow-liver-kidney transplants.
- We have performed more than 100 liver transplants
- Our program includes two transplant hepatologists
- We have pediatric anesthesiologists with special training in transplantation
- Our critical care physicians have experience in the care of transplant recipients
- We are one of only a few centers in the country to offer liver transplantation as a treatment option for children with rare genetic disorders such as metabolic liver disease.
- Our highly skilled transplant specialists have performed liver transplants on patients as young as three weeks old.
- Children's Hospital's Solid Organ Transplant Program ranks in the top 25 percent of pediatric transplant programs for volume.
Johnny C. Hong, MD
, FACS, is a Hepatobiliary and Transplant surgeon and program director of Solid Organ Transplantation at Froedtert & The Medical College of Wisconsin and Children's Hospital of Wisconsin. Dr. Hong is a highly accomplished, innovative clinician and researcher. His clinical expertise encompasses the entire spectrum of multi-organ transplantation (liver, kidney, pancreas and intestine) and hepatobiliary surgery for adults and children. His laboratory research has focused on developing new treatments in organ resuscitation to mitigate the adverse effects of ischemia and reperfusion injury with the goal of reducing the number of patient deaths on the transplant waitlist by converting organs that would otherwise be discarded to transplantable status.
Prior to joining Froedtert & The Medical College of Wisconsin and Children's Hospital of Wisconsin, Dr. Hong was on the surgical faculty at the University of California, Los Angeles (UCLA), where he was director of the Liver and Pancreas Transplantation and Live Donor Liver Transplantation programs. He is board certified in general surgery by the American Board of Surgery, with fellowship training and certification in immunology and organ transplantation (University of Texas Health Science Center at Houston), and multiorgan transplantation and hepatobiliary surgery (UCLA).